Assessing Kidney Transplantation Using ECMO-Supported Donors Within a KDPI-Based Allocation System.
Journal
Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
31
05
2023
accepted:
16
06
2023
medline:
13
10
2023
pubmed:
13
10
2023
entrez:
13
10
2023
Statut:
epublish
Résumé
Organ donors supported by extracorporeal membrane oxygenation (ECMO) have historically been considered high-risk and are judiciously utilized. This study examines transplant outcomes using renal allografts from donors supported on ECMO for nondonation purposes. Retrospective review of the Gift of Life (Pennsylvania, New Jersey, Delaware) organ procurement organization database, cross-referenced to the Organ Procurement and Transplantation Network database, assessed kidney transplants using donors supported on venoarterial (VA) and venovenous (VV) ECMO for nondonation purposes. Transplants using VA- and VV-ECMO donors were compared with Kidney Donor Profile Index (KDPI)-stratified non-ECMO donors. Regression modeling of the entire ECMO and non-ECMO populations assessed ECMO as predictive of graft survival. Additional regression of the ECMO population alone assessed for donor features associated with graft survival. Seventy-eight ECMO donors yielded 128 kidney transplants (VA: 80, VV: 48). Comparing outcomes using these donors to kidney transplants using organs from KDPI-stratified non-ECMO donors, VA- and VV-ECMO donor grafts conferred similar rates of delayed graft function and posttransplant renal function to KDPI-matched non-ECMO counterparts. VA-ECMO kidneys demonstrated superior graft survival compared with the lowest-quality (KDPI 86%-100%) non-ECMO kidneys and similar graft survival to KDPI <85% non-ECMO kidneys. VV-ECMO showed inferior graft survival to all but the lowest-quality (KDPI 86%-100%) non-ECMO kidneys. VV-ECMO, but not VA-ECMO, was associated with increased risk of graft loss on multivariable regression (hazard ratios-VA: 1.02, VV: 2.18). Higher KDPI, advanced age, increased body mass index, hypertension, and diabetes were identified as high-risk features of ECMO donors. Kidney transplantation using appropriately selected ECMO donors can safely expand the donor pool. Ongoing studies are necessary to determine best practice patterns using kidneys from these donors.
Sections du résumé
Background
UNASSIGNED
Organ donors supported by extracorporeal membrane oxygenation (ECMO) have historically been considered high-risk and are judiciously utilized. This study examines transplant outcomes using renal allografts from donors supported on ECMO for nondonation purposes.
Methods
UNASSIGNED
Retrospective review of the Gift of Life (Pennsylvania, New Jersey, Delaware) organ procurement organization database, cross-referenced to the Organ Procurement and Transplantation Network database, assessed kidney transplants using donors supported on venoarterial (VA) and venovenous (VV) ECMO for nondonation purposes. Transplants using VA- and VV-ECMO donors were compared with Kidney Donor Profile Index (KDPI)-stratified non-ECMO donors. Regression modeling of the entire ECMO and non-ECMO populations assessed ECMO as predictive of graft survival. Additional regression of the ECMO population alone assessed for donor features associated with graft survival.
Results
UNASSIGNED
Seventy-eight ECMO donors yielded 128 kidney transplants (VA: 80, VV: 48). Comparing outcomes using these donors to kidney transplants using organs from KDPI-stratified non-ECMO donors, VA- and VV-ECMO donor grafts conferred similar rates of delayed graft function and posttransplant renal function to KDPI-matched non-ECMO counterparts. VA-ECMO kidneys demonstrated superior graft survival compared with the lowest-quality (KDPI 86%-100%) non-ECMO kidneys and similar graft survival to KDPI <85% non-ECMO kidneys. VV-ECMO showed inferior graft survival to all but the lowest-quality (KDPI 86%-100%) non-ECMO kidneys. VV-ECMO, but not VA-ECMO, was associated with increased risk of graft loss on multivariable regression (hazard ratios-VA: 1.02, VV: 2.18). Higher KDPI, advanced age, increased body mass index, hypertension, and diabetes were identified as high-risk features of ECMO donors.
Conclusions
UNASSIGNED
Kidney transplantation using appropriately selected ECMO donors can safely expand the donor pool. Ongoing studies are necessary to determine best practice patterns using kidneys from these donors.
Identifiants
pubmed: 37829245
doi: 10.1097/TXD.0000000000001521
pmc: PMC10566806
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1521Informations de copyright
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Card Surg. 2020 Oct;35(10):2814-2816
pubmed: 32939787
Eur J Pediatr Surg. 2010 Jan;20(1):1-4
pubmed: 19746333
Transplant Proc. 2014 May;46(4):1061-3
pubmed: 24815128
Transplant Proc. 2016 Sep;48(7):2458-2460
pubmed: 27742321
Surgery. 1987 Oct;102(4):724-30
pubmed: 2821641
Cardiorenal Med. 2015 Dec;6(1):50-60
pubmed: 27194996
J Crit Care. 2012 Oct;27(5):524.e7-14
pubmed: 22386227
Am J Surg. 2000 Aug;180(2):144-54
pubmed: 11044532
J Trauma. 2005 Jun;58(6):1095-101; discussion 1101-2
pubmed: 15995454
World J Clin Cases. 2020 Feb 6;8(3):540-545
pubmed: 32110664
Clin Transplant. 2016 Oct;30(10):1306-1313
pubmed: 27460305
Cardiovasc Revasc Med. 2022 Nov;44:1-7
pubmed: 35853815
Crit Care Med. 2020 May;48(5):e400-e408
pubmed: 32118700
Am J Transplant. 2019 Feb;19(2):434-447
pubmed: 29947163
Crit Care. 2016 Nov 28;20(1):387
pubmed: 27890016
Artif Organs. 2014 May;38(5):426-31
pubmed: 24117786
J Thorac Surg. 1953 Dec;26(6):598-616; discussion 631-2
pubmed: 13109890
Transplant Proc. 2018 Sep;50(7):1957-1961
pubmed: 30177087
Crit Care Med. 2017 Oct;45(10):1734-1741
pubmed: 28640022
Transplantation. 2009 Jul 27;88(2):231-6
pubmed: 19623019
Crit Care. 2021 Jan 28;25(1):38
pubmed: 33509228
Clin J Am Soc Nephrol. 2012 Aug;7(8):1328-36
pubmed: 22498496
Clin Transplant. 2014 Jul;28(7):816-20
pubmed: 24805948
Ann Transplant. 2004;9(1):57-8
pubmed: 15478893
J Formos Med Assoc. 2014 Nov;113(11):778-85
pubmed: 24928419